18.32
18.32 (0%)
As of Feb 14, 2025
Clearpoint Neuro, Inc. [CLPT]
Source:
Company Overview
Clearpoint Neuro, Inc. is a commercial-stage medical device company, incorporated in 1998 as a Delaware corporation, that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain.
Country | United States |
Headquarters | solana beach, california |
Phone Number | (888) 287-9109 |
Industry | manufacturing |
CEO | Joseph M. Burnett |
Website | www.clearpointneuro.com |
Financial Year:
Financial Overview (Dollars in Millions)
Revenue | $31.4 |
Operating Profit | $-19.7 |
Net Income | $-18.9 |
Net Cash | $-3 |
Profit Ratios
Gross Margin | $19.1 |
Operating Margin | -62.9 |
Profit as % of Revenues | -101.1% |
Profit as % of Assets | -46.2% |
Profit as % of Stockholder Equity | -74.5% |
Management Effectiveness
Return on Equity | -74.5% |
Return on Assets | -48.3% |
Turnover Ratio | 76.7% |
EBITA | $-19.7 |
Balance Sheet and Cash Flow Measures
Total Assets | $39.2 |
Total Liabilities | $13.8 |
Operating Cash Flow | $-9 |
Investing Cash Flow | $-0.3 |
Financing Cash Flow | $6.2 |